CA-43-WF29_10uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=10uM, (2R)-1-[2-[hydroxy(phosphonooxy)phosphoryl]oxyacetyl]pyrrolidine-2-carboxylic acid, Cholesterol Biosynthesis Inhibitors targeting MVD (Novartis, 44306159)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/44306159
Similar Terms
Downloads & Tools

Genes

16 genes differentially expressed following the CA-43-WF29_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RPL37 ribosomal protein L37 1.29049
ANAPC11 anaphase promoting complex subunit 11 0.740982
RPL27A ribosomal protein L27a 0.540156
RPS16 ribosomal protein S16 0.515324
VIM vimentin 0.508927
RPL27 ribosomal protein L27 0.452721
LGALS1 lectin, galactoside-binding, soluble, 1 0.402034
FKBP1A FK506 binding protein 1A, 12kDa 0.400896
CATSPER3 cation channel, sperm associated 3 0.272681
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 0.217939
GPX4 glutathione peroxidase 4 0.214531

decreased expression

Symbol Name Standardized Value
PKM pyruvate kinase, muscle -0.278136
FKBP4 FK506 binding protein 4, 59kDa -0.250093
ACTG1 actin gamma 1 -0.24429
UBL4A ubiquitin-like 4A -0.228723
POTEF POTE ankyrin domain family, member F -0.213076